Diagnostics hits Merck's laboratory sales in first half
This article was originally published in Clinica
Executive Summary
Merck's declining presence in the diagnostics business adversely affected its laboratory division in the first half of 1997 and the worldwide squeeze in the contrast imaging market depressed its pharmaceutical figures.